Results 261 to 270 of about 191,701 (337)
Abstract A population pharmacokinetic (PK) covariate analysis was conducted utilizing data from adolescents and children ≥8 to <12 years of age with heterozygous familial hypercholesterolemia. One phase II and 1 phase III study were analyzed (121 patients on active treatment).
Pavel Kovalenko+5 more
wiley +1 more source
Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou+6 more
wiley +1 more source
Factors influencing glycocalyx degradation: a narrative review. [PDF]
Wang J, Ma L, Fang Y, Ye T, Li H, Lan P.
europepmc +1 more source
Atherogenic circulating lipoproteins in ischemic stroke. [PDF]
Benitez S+3 more
europepmc +1 more source
Scenarios of drug exposure and administration as well as detection assays for drugs and methods of sports doping published between 2023 and 2024 are critically reviewed and evaluated in context with the Prohibited List 2024 as established by the World Anti‐Doping Agency.
Mario Thevis+2 more
wiley +1 more source
Stationary screen time, blood lipids, and atherosclerotic cardiovascular disease incidence. [PDF]
Liu Y, Xu L, Liu P, Liao X, Liao J.
europepmc +1 more source
Abstract Background The emergence of multicellularity in animals marks a pivotal evolutionary event, which was likely enabled by molecular innovations in the way cells adhere and communicate with one another. β‐Catenin is significant to this transition due to its dual role as both a structural component in the cadherin–catenin complex and as a ...
Brian M. Walters+5 more
wiley +1 more source
The role of lipoprotein sulfatides in MASLD fibrosis transition: A new frontier in hepatic immunomodulation. [PDF]
Zhou Y, Liu J.
europepmc +1 more source